Concepts (84)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Angioplasty, Balloon, Coronary | 6 | 2011 | 172 | 0.950 |
Why?
|
| Transcatheter Aortic Valve Replacement | 2 | 2024 | 192 | 0.900 |
Why?
|
| Aortic Valve Stenosis | 2 | 2024 | 325 | 0.860 |
Why?
|
| Angina, Unstable | 3 | 2010 | 52 | 0.690 |
Why?
|
| Anticoagulants | 3 | 2010 | 585 | 0.620 |
Why?
|
| Fibrinolytic Agents | 2 | 2009 | 199 | 0.540 |
Why?
|
| Enoxaparin | 2 | 2009 | 42 | 0.520 |
Why?
|
| Myocardial Infarction | 5 | 2011 | 997 | 0.500 |
Why?
|
| Hirudins | 1 | 2013 | 37 | 0.430 |
Why?
|
| Antithrombins | 1 | 2013 | 55 | 0.420 |
Why?
|
| Blood Coagulation | 1 | 2013 | 119 | 0.410 |
Why?
|
| Acute Coronary Syndrome | 1 | 2013 | 201 | 0.350 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2013 | 226 | 0.330 |
Why?
|
| Peptide Fragments | 1 | 2013 | 747 | 0.330 |
Why?
|
| Thrombosis | 2 | 2013 | 517 | 0.300 |
Why?
|
| Coronary Thrombosis | 1 | 2007 | 33 | 0.290 |
Why?
|
| Heparin | 1 | 2009 | 229 | 0.280 |
Why?
|
| Mammary Arteries | 1 | 2005 | 26 | 0.240 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2005 | 95 | 0.240 |
Why?
|
| Aortic Valve | 2 | 2024 | 428 | 0.230 |
Why?
|
| Blood Coagulation Tests | 1 | 2003 | 60 | 0.220 |
Why?
|
| Embolization, Therapeutic | 1 | 2005 | 226 | 0.200 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2023 | 138 | 0.190 |
Why?
|
| Risk Assessment | 3 | 2024 | 3325 | 0.170 |
Why?
|
| Heart Valve Prosthesis | 1 | 2023 | 292 | 0.170 |
Why?
|
| Coronary Disease | 1 | 2003 | 638 | 0.170 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2023 | 425 | 0.150 |
Why?
|
| Hemorrhage | 2 | 2013 | 459 | 0.150 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2009 | 256 | 0.130 |
Why?
|
| Risk Factors | 2 | 2024 | 9974 | 0.130 |
Why?
|
| Electrocardiography | 2 | 2011 | 961 | 0.110 |
Why?
|
| Whole Blood Coagulation Time | 1 | 2013 | 12 | 0.110 |
Why?
|
| Coronary Artery Disease | 2 | 2011 | 743 | 0.100 |
Why?
|
| Coronary Vasospasm | 1 | 2011 | 10 | 0.100 |
Why?
|
| Stents | 3 | 2009 | 866 | 0.090 |
Why?
|
| Chest Pain | 1 | 2011 | 125 | 0.090 |
Why?
|
| Humans | 10 | 2024 | 122998 | 0.090 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 2007 | 61 | 0.090 |
Why?
|
| Middle Aged | 5 | 2013 | 25931 | 0.080 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 1390 | 0.080 |
Why?
|
| Injections, Subcutaneous | 1 | 2009 | 126 | 0.080 |
Why?
|
| Platelet Count | 1 | 2009 | 133 | 0.080 |
Why?
|
| Injections, Intravenous | 1 | 2009 | 252 | 0.080 |
Why?
|
| Troponin I | 1 | 2009 | 98 | 0.070 |
Why?
|
| Ticlopidine | 1 | 2007 | 28 | 0.070 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2007 | 23 | 0.070 |
Why?
|
| Hemoglobins | 1 | 2009 | 300 | 0.070 |
Why?
|
| Treatment Outcome | 3 | 2023 | 12087 | 0.070 |
Why?
|
| Administration, Oral | 1 | 2009 | 671 | 0.070 |
Why?
|
| Aspirin | 1 | 2007 | 224 | 0.060 |
Why?
|
| Odds Ratio | 1 | 2009 | 1245 | 0.060 |
Why?
|
| Peptides | 1 | 2009 | 798 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2011 | 1870 | 0.060 |
Why?
|
| Drug Therapy, Combination | 1 | 2007 | 1148 | 0.060 |
Why?
|
| Hematologic Agents | 1 | 2003 | 6 | 0.060 |
Why?
|
| Logistic Models | 1 | 2009 | 1796 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2007 | 614 | 0.060 |
Why?
|
| Male | 5 | 2013 | 59901 | 0.050 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2005 | 230 | 0.050 |
Why?
|
| Hyperlipidemias | 1 | 2005 | 174 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 2 | 2007 | 1253 | 0.050 |
Why?
|
| Time Factors | 1 | 2013 | 6198 | 0.050 |
Why?
|
| Coronary Angiography | 1 | 2005 | 417 | 0.050 |
Why?
|
| Allografts | 1 | 2023 | 189 | 0.050 |
Why?
|
| Coronary Artery Bypass | 1 | 2005 | 485 | 0.050 |
Why?
|
| Ultrasonography | 1 | 2005 | 945 | 0.040 |
Why?
|
| Prosthesis Design | 1 | 2023 | 667 | 0.040 |
Why?
|
| Biomarkers | 1 | 2009 | 2940 | 0.040 |
Why?
|
| Cardiac Catheterization | 1 | 2003 | 634 | 0.040 |
Why?
|
| Aorta, Thoracic | 1 | 2023 | 516 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2013 | 15931 | 0.040 |
Why?
|
| Female | 4 | 2023 | 65310 | 0.030 |
Why?
|
| Hypertension | 1 | 2005 | 1277 | 0.030 |
Why?
|
| Adult | 3 | 2023 | 28980 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2005 | 1224 | 0.030 |
Why?
|
| Aged | 2 | 2011 | 19035 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 2011 | 321 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 2021 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 2105 | 0.020 |
Why?
|
| Economics, Pharmaceutical | 1 | 2003 | 8 | 0.010 |
Why?
|
| Factor Xa Inhibitors | 1 | 2003 | 64 | 0.010 |
Why?
|
| Child | 1 | 2023 | 24144 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 6359 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2003 | 1088 | 0.010 |
Why?
|